Types of Antidepressants: How SSRIs, SNRIs, NDRIs, Tricyclics, and Atypical Antidepressants Differ Reader-friendly overview This article compares the main antidepressant classes by mechanism, common examples, side-effect patterns, and the practical reasons a clinician may choose one class over another. SSRIs SNRIs NDRIs Tricyclics Atypical antidepressants Medical disclaimer This content is for educational purposes only. It…

Early Weeks on Psychiatric Medication: What Doctors Watch for After Starting Treatment Why The First 1–4 Weeks Matter The first few weeks after starting a psychiatric medication are often less about judging the final outcome and more about answering a more immediate question: is this treatment tolerable enough to continue? In many cases, benefits take…

From Weeks to Hours: How Rapid-Acting Antidepressants Are Changing Expectations in 2026 Introduction For much of modern psychiatry, time has been treated as an unavoidable constraint. Antidepressants were understood to require four to six weeks before meaningful improvement could be assessed, and this delay became embedded in clinical routines, treatment guidelines, and patient expectations. Clinicians…

Antidepressants without Guessing: How They Are Trying To Predict Treatment Response in 2026 Medically reviewed by John Smith, Jane Doe, Sarah Wilson Introduction For decades, prescribing antidepressants has followed a pattern that would feel out of place in most other areas of medicine. A clinician evaluates symptoms, considers comorbidities and prior history, selects a medication…

Antidepressants Are No Longer Just About Serotonin Medically reviewed by PChina Jin LI (李锦) Institute of toxicology, Academy of Military Medical Sciences, Beijing For several decades, the treatment of depression has been organized around a relatively simple biological idea: that mood disorders are primarily linked to disturbances in monoamine neurotransmitters, especially serotonin. This model, often…

Strong Heterogeneity in Physical Side Effects Between Antidepressants: Clinical Meaning of the 2025 Lancet Network Meta-Analysis by Darrel A. REGIER The Scope and Design of the Network Meta-Analysis The October 2025 Lancet network meta-analysis (NMA) represents one of the most comprehensive comparative assessments of physical side effects among antidepressants to date. By synthesizing data from…

Escitalopram: Why “Going Off an Antidepressant” Is Sometimes Harder Than Starting — Withdrawal, Relapse, and the Role of Genetics Withdrawal vs. Relapse: The Clinical Mistake That Changes Everything Starting escitalopram is usually straightforward. You begin with a low dose. Over a few weeks, mood stabilizes. Anxiety softens. Sleep improves. The process is gradual, and many…

Bupropion: An Antidepressant “With Energy” — Where Is the Line Between Benefit and Risk of Abuse? Why Bupropion Is Different — and Who It Helps Most Most antidepressants work mainly on serotonin. Bupropion does not. That difference is not small. It explains why many patients describe bupropion as “activating,” “energizing,” or even “motivating” compared with…

PDE5 Inhibitors and Antidepressants: Tadalafil (Cialis) and Sildenafil (Viagra) with SSRIs like Lexapro and Zoloft Compatibility, Libido, and Mood Medically reviewed by PChina Jin LI (李锦) Institute of toxicology, Academy of Military Medical Sciences, Beijing Depression, SSRIs, and sexual function: the clinical background Sexual dysfunction is deeply intertwined with depressive disorders, both as a core…

Akathisia on Aripiprazole: How Common Is It, How to Distinguish It from Anxiety, and How to Manage It How common is akathisia with aripiprazole Akathisia is a movement disorder characterized by a subjective feeling of inner restlessness accompanied by mental distress and/or an inability to sit still. Akathisia is a well-recognized adverse effect of antipsychotic…